Form 4: Tandem Diabetes Care Executive Elizabeth Gasser Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


EVP and Chief Strategy Officer of Tandem Diabetes Care, Elizabeth Gasser, reports the vesting of restricted stock units and associated tax withholding.

Summary

  • On February 27, 2024, Elizabeth Gasser, EVP and Chief Strategy Officer of Tandem Diabetes Care, reported transactions involving Tandem Diabetes Care Inc. common stock.
  • Gasser acquired 372 shares of common stock through the vesting of restricted stock units (RSUs).
  • 130 shares were withheld by the company to satisfy tax withholding requirements related to the RSU vesting at a price of $27.34.
  • Following these transactions, Gasser directly owns 6,423 shares of Tandem Diabetes Care Inc. common stock and 373 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies within the medical device industry.

Comparison to Industry Standards

  • Executive compensation packages including RSUs are standard practice among publicly traded companies like Tandem Diabetes Care, Insulet, and Dexcom.
  • The vesting schedules and tax withholding practices are generally consistent with industry norms for equity compensation.

Stakeholder Impact

  • The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
  • The filing provides transparency regarding executive stock ownership, which can be of interest to shareholders.

Key Dates

DateDescription
May 27, 2020Date RSUs were awarded pursuant to the 2013 Stock Incentive Plan.
May 27, 2021First vesting date of the RSUs (25%).
February 27, 2024Date of the reported stock transactions (RSU vesting and tax withholding).
February 29, 2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.